Analysen von Peter Welford
| 06.02.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 05.02.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 31.01.25 | Novartis Hold | Jefferies & Company Inc. | |
| 24.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 20.01.25 | GSK Hold | Jefferies & Company Inc. | |
| 20.01.25 | Novartis Hold | Jefferies & Company Inc. | |
| 20.01.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 06.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 20.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 17.12.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 10.12.24 | GSK Hold | Jefferies & Company Inc. | |
| 10.12.24 | Novartis Hold | Jefferies & Company Inc. | |
| 10.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 10.12.24 | Roche Hold | Jefferies & Company Inc. | |
| 10.12.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.12.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 01.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 20.11.24 | QIAGEN Hold | Jefferies & Company Inc. | |
| 20.11.24 | Roche Hold | Jefferies & Company Inc. | |
| 12.11.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.11.24 | GSK Hold | Jefferies & Company Inc. | |
| 06.11.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 25.10.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 23.10.24 | Roche Hold | Jefferies & Company Inc. | |
| 21.10.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 17.10.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 08.10.24 | GSK Buy | Jefferies & Company Inc. | |
| 03.10.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 03.10.24 | GSK Buy | Jefferies & Company Inc. | |
| 20.09.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 18.09.24 | GSK Buy | Jefferies & Company Inc. | |
| 03.09.24 | Novartis Hold | Jefferies & Company Inc. | |
| 02.09.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 07.08.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.08.24 | QIAGEN Hold | Jefferies & Company Inc. | |
| 01.08.24 | Roche Hold | Jefferies & Company Inc. | |
| 25.07.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 25.07.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 25.07.24 | Roche Hold | Jefferies & Company Inc. | |
| 24.07.24 | GSK Buy | Jefferies & Company Inc. | |
| 18.07.24 | Novartis Buy | Jefferies & Company Inc. | |
| 17.07.24 | Roche Hold | Jefferies & Company Inc. | |
| 02.07.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 02.07.24 | Roche Hold | Jefferies & Company Inc. | |
| 02.07.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.07.24 | GSK Buy | Jefferies & Company Inc. | |
| 02.07.24 | Novartis Buy | Jefferies & Company Inc. | |
| 02.07.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 24.06.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 17.06.24 | GSK Buy | Jefferies & Company Inc. | |